Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.
about
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cellsPlatelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureUse of platelet lysate for bone regeneration - are we ready for clinical translation?Using mesenchymal stem cells as a therapy for bone regeneration and repairingThe influence of platelet-derived products on angiogenesis and tissue repair: a concise updateMesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsMaking the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell ExpansionDonor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cellsFeasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against StrokeMultipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.Skeletal tissue engineering using mesenchymal or embryonic stem cells: clinical and experimental data.Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells.The production method affects the efficacy of platelet derivatives to expand mesenchymal stromal cells in vitro.Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approachThrombin promotes fibronectin secretion by bone marrow mesenchymal stem cells via the protease-activated receptor mediated signalling pathways.Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro.Platelet-rich plasma induces post-natal maturation of immature articular cartilage and correlates with LOXL1 activation.Clinical applications of platelet-rich plasma in patellar tendinopathyChanges in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications.Enhanced cellular responses of human bone marrow stromal cells cultured on pretreated surface with allogenic platelet-rich plasma.Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation.Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cellsSafety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular jointsPlatelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness.Human bone marrow-derived mesenchymal stem cells.Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.Effect of platelet lysate on human cells involved in different phases of wound healingMesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.Platelet-rich plasma, especially when combined with a TGF-β inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro.CCL20, γδ T cells, and IL-22 in corneal epithelial healing.Morphological study of isolated ovarian preantral follicles using fibrin gel plus platelet lysate after subcutaneous transplantationBioengineering a human plasma-based epidermal substitute with efficient grafting capacity and high content in clonogenic cellsA chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin wounds.Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications.Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease
P2860
Q21245484-E54EA33F-A16B-4A80-9A22-15B3DEA8C193Q26740490-A763F5A2-83D3-4EEC-9C87-8CC60168C5BFQ26765255-3C019219-E083-44E7-9E8C-D4FF8F40DB10Q26777025-4A57CFA1-8010-454F-A0EE-9ACA5F0EAC58Q26779664-C3C42BC0-1E22-4336-BA31-E84953275AD9Q26825272-4569A41B-CD08-4E1C-A7E3-D43152927034Q28079823-BDBB2474-3EEA-4680-BB41-259F79547B04Q28079988-821278BD-38B9-441C-B390-11A79A71B689Q28729211-FB2E2CCA-CCFE-4B4C-88C9-81B500D00266Q30370083-5611176E-5397-4A23-B4F9-E67CD75A7357Q30478228-22E76F64-32AA-4781-8497-FD413347BB19Q30859101-9C642DA0-026C-47B4-BA2A-55ED0339286DQ33527133-CE60F3FE-B196-44A1-BBAB-B9DAC30CB245Q33623503-3D79DE68-57BB-4036-86D9-5C2570B7A2FAQ33706611-E5EFECC4-381D-484F-9D39-AE20C976976AQ33746604-1FE25407-3491-4813-ACA8-B73500BE20B8Q33802826-233D929C-6E80-42AD-A6B8-601355AD4770Q33807739-E4662930-7914-460B-9C1F-60C1731287F0Q34022507-4B2520A0-0A75-4A46-91D6-0FEA81BD76E3Q34071520-D22CEB68-BBBB-48AA-9047-C392CEB7B805Q34157503-AD97CC9E-8494-4C0C-BA69-48A2BFB592A3Q34391255-C2AB820C-F40C-42CF-9E52-CBE423D55970Q34411454-460549D4-4666-4E3F-8A18-BF9E746B1A88Q34449618-505999A3-CC88-4099-8004-4322803B923AQ34769510-7F7FCECA-A96E-410E-97CA-4C6A9204322DQ34803950-704AFAF5-EA72-4519-BFCA-E6B7705B334AQ35029446-86E2B340-2C40-460E-90B0-59C8D1FB778BQ35081031-6AD59782-C97B-44E6-A674-FF88B54BD82BQ35082549-E135C00D-4842-446C-BE95-150781844412Q35094973-A3200B37-E188-4394-AFA1-A75A6485CBA6Q35105392-373F7F55-5722-44C1-A101-881A6B5825C6Q35369424-4B569EAD-72CD-4064-984B-DC2740F8379DQ35665288-4BC9008A-A046-4468-A861-8CCA269A43FDQ35685772-66C1E994-A45E-428F-93BA-CB2859EC5E98Q35768173-45FEF88E-586D-4DB9-B01B-F1BAA5B64206Q35769026-11C92DD0-7F73-41C0-8393-8F6CD06BA51CQ35863421-ECEEB416-5DAE-4C90-8D4C-59C46D778629Q35923384-63372D83-2681-4755-BA2D-620A5101BED9Q35951874-66AF1401-E47E-4EBB-B6FF-A7B662167B23Q35971980-03610CE3-27D7-46B5-8DA4-2AF6635FE6D0
P2860
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Platelet lysates promote mesen ...... ll-based therapy applications.
@en
Platelet lysates promote mesen ...... ll-based therapy applications.
@nl
type
label
Platelet lysates promote mesen ...... ll-based therapy applications.
@en
Platelet lysates promote mesen ...... ll-based therapy applications.
@nl
prefLabel
Platelet lysates promote mesen ...... ll-based therapy applications.
@en
Platelet lysates promote mesen ...... ll-based therapy applications.
@nl
P2093
P356
P1476
Platelet lysates promote mesen ...... ll-based therapy applications.
@en
P2093
Christelle Doucet
Isabelle Ernou
Jean-Roch Llense
Laurent Begot
Xavier Holy
Yizhou Zhang
P304
P356
10.1002/JCP.20391
P577
2005-11-01T00:00:00Z